KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Tenet Healthcare (THC) over the last 17 years, with Q4 2025 value amounting to $121.0 million.

  • Tenet Healthcare's Gains from Investment Securities fell 8743.51% to $121.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $450.0 million, marking a year-over-year decrease of 6459.48%. This contributed to the annual value of $450.0 million for FY2025, which is 6459.48% down from last year.
  • As of Q4 2025, Tenet Healthcare's Gains from Investment Securities stood at $121.0 million, which was down 8743.51% from $87.0 million recorded in Q3 2025.
  • Tenet Healthcare's 5-year Gains from Investment Securities high stood at $963.0 million for Q4 2024, and its period low was -$28.0 million during Q1 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $42.5 million (2023), whereas its average is $110.8 million.
  • As far as peak fluctuations go, Tenet Healthcare's Gains from Investment Securities plummeted by 11052.63% in 2021, and later soared by 300645.16% in 2024.
  • Quarter analysis of 5 years shows Tenet Healthcare's Gains from Investment Securities stood at $146.0 million in 2021, then tumbled by 91.1% to $13.0 million in 2022, then surged by 138.46% to $31.0 million in 2023, then skyrocketed by 3006.45% to $963.0 million in 2024, then tumbled by 87.44% to $121.0 million in 2025.
  • Its last three reported values are $121.0 million in Q4 2025, $87.0 million for Q3 2025, and $235.0 million during Q2 2025.